Products Obiltoxaximab was approved in the United States in 2016 as an infusion product (Anthim). It has not yet been registered in many countries. Obiltoxaximab was developed with funding from national organizations and is intended primarily for the treatment of victims of a terrorist attack with anthrax spores (Strategic National Stockpile). Structure and properties Obiltoxaximab … Obiltoxaximab
Symptoms Depending on the organs affected, the following clinical pictures are distinguished: Cutaneous anthrax Pulmonary anthrax Gastrointestinal anthrax Injection anthrax is observed when contaminated illicit heroin is injected intravenously. Typical symptoms of anthrax include fever, aching limbs, headache, sweating, chills and edema. Anthrax can lead to blood poisoning, meningitis, and organ failure, among other symptoms, … Anthrax Symptoms, Causes and Treatment
Products The first therapeutic monoclonal antibody was approved in 1986. Muromonab-CD3 (Orthoclone OKT3) binds to the CD3 receptor on T cells and has been used in transplantation medicine. Numerous drugs containing antibodies are now available. A selection of active substances can be found at the end of this article. These are expensive drugs. For example, … Monoclonal Antibodies